Background: Indications, efficacy, and safety of plasma products are highly debated. We compared the concentrations of haemostatic proteins and cytokines in solvent/detergent-treated plasma (SDP) and fresh-frozen plasma (FFP).
The FDA has granted approval to EMD Serono for Gonal-f RFF Redi-ject (follitropin alfa injection), a disposable pre-filled drug injector...
A Phase II clinical trial for F 627,recombinant G-CSF from Generon(Shanghai)Corporation, has been started after FDA regulatory clearance. The study...
Lantheus Medical Imaging has announced that results from its first Phase III study of flurpiridaz F 18 for myocardial perfusion...
Generon Corporation announced that the first pivotal phase III study in the U.S. for F 627 to treat chemotherapy-induced neutropenia...